Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Calgene Inc. on Friday took preemptive action against Enzo Biochem Inc., filing suit to have ENZ's pending antisense patent declared invalid and not infringed
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury